Senior Director, US Brukinsa HCP and DTC Marketing at BeiGene | USA | $225K/yr – $295K/yr

BeiGene

Senior Director, US Brukinsa HCP and DTC Marketing

USA (Remote)

$225K/yr – $295K/yrSenior Level12+ years expFull time

Posted 5 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own US promotional strategy and cross-functional messaging for a leading oncology portfolio, with a sharp emphasis on field feedback, DTC TV, and compliance; drive measurable promo impact through market research and analytics, while aligning with budgets and leadership conversations.

Promotional Strategy: Own the US Brukinsa plan from messaging to tactics, grounded in field perspectives.
Cross-Functional Execution: Coordinate with Sales, Market Access, Medical Affairs, and PRC to align on messaging and plan impact.
Measurement & Compliance: Partner with Analytics to assess effectiveness and ensure adherence to guidelines and laws.

Job Description

Responsibilities

Lead and execute US promotional strategy for Brukinsa, including messaging and promotional tactics.
Ensure strategies reflect field insights by partnering with Sales leadership.
Develop and implement the DTC TV strategy with the NPP lead.
Collaborate with Market Access, Medical Affairs, Patient Advocacy, and Corporate Affairs.
Manage PRC partnerships to evaluate promotional messaging.
Partner with Business Analytics to align market research and measure effectiveness.
Monitor the business landscape for customer and competitor insights to inform plans.
Ensure marketing activities comply with guidelines and local laws.
Communicate brand updates and tactics across QBRs, Field Meetings, and Leadership Meetings.
Contribute to the annual operating plan and supervise vendors within budget.

BeiGene

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.

Founded in 2010

Cambridge, Massachusetts, USA

2.4K employees (105 in marketing)

beonemedicines.com